We selected four tumors for that analysis and two of them (PAAD and HNSC) experienced a negative correlation between CDKN2A alteration and CD8 infiltration, while the other two tumors (BLCA and LUSC) did not experience that correlation. This evidence concerns the gene CDKN2A and pancreatic adenocarcinoma.